TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

At TCR2 Therapeutics we have a bold vision to cure cancer by using our immune system in a more natural way.
Founded
2015
Raised
$169.5M
Follow us
Alexa global traffic share
Latest funding
$125,000,000
Venture capital (Series B) - 2018
Redmile Group Hillhouse Capital Group MPM Capital +12
$44,500,000
Venture capital (Series A) - 2016
MPM Capital F2 Ventures
Team Size
10+
Employees
$125,000,000 Venture capital (Series B)
FinSMEs

TCR2 Therapeutics Raises $125M in Series B Financing

Funding Science